Literature DB >> 16824855

Circulating endothelial progenitor cells predict coronary artery disease severity.

Geoffrey A Kunz1, Ge Liang, Florim Cuculi, Florim Cuculoski, David Gregg, Korkut C Vata, Linda K Shaw, Pascal J Goldschmidt-Clermont, Chunming Dong, Doris A Taylor, Eric D Peterson.   

Abstract

BACKGROUND: Circulating endothelial progenitor cells (EPCs) may play an important role in the body's defense against atherosclerosis. Previous studies have shown an association between EPC numbers and the presence of traditional coronary artery disease (CAD) risk factors. The relationship between EPC numbers and the severity of atherosclerosis is, however, not known.
METHODS: EPC counts were measured by quantitative cell culture in 122 patients undergoing diagnostic cardiac catheterization. The association between patients' EPC count and the presence of multivessel CAD and traditional cardiac risk factors was assessed using logistic regression analysis.
RESULTS: The median age of the study population was 58 years; 37% had multivessel CAD, 29% had diabetes, and 14% had myocardial infarction this admission. EPC counts did not vary significantly with most established cardiac risk factors but were lower in diabetics versus nondiabetics and trended toward lower numbers in older patients. EPC count was the second strongest predictor of multivessel CAD, after patient age. Patients with multivessel disease had significantly lower EPC counts than those without (median, 3 vs 13; P < .0088). For every 10 colony forming unit increase in EPCs, a patient's likelihood for multivessel CAD declined by 20% (P < .001).
CONCLUSION: This study demonstrates an inverse relationship between circulating EPCs and CAD severity, independent of traditional risk factors. If confirmed in ongoing studies, this may represent an important new diagnostic and therapeutic target for coronary disease treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16824855     DOI: 10.1016/j.ahj.2006.02.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  54 in total

1.  Jay and Jeanie Schottenstein prize in cardiovascular science: predicting cardiovascular illnesses for the 21(st) century, and the unpredictable...

Authors:  Pascal J Goldschmidt-Clermont
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

2.  Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome.

Authors:  Ishwarlal Jialal; Gian Paolo Fadini; Kari Pollock; Sridevi Devaraj
Journal:  Am J Cardiol       Date:  2010-09-21       Impact factor: 2.778

Review 3.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

4.  Dysfunction of circulating endothelial progenitor cells in type 1 diabetic rats with diabetic retinopathy.

Authors:  Wei Zhang; Hua Yan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-06       Impact factor: 3.117

5.  Glucose tolerance is negatively associated with circulating progenitor cell levels.

Authors:  G P Fadini; L Pucci; R Vanacore; I Baesso; G Penno; A Balbarini; R Di Stefano; R Miccoli; S de Kreutzenberg; A Coracina; A Tiengo; C Agostini; S Del Prato; A Avogaro
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

6.  Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations.

Authors:  Thomas J Povsic; Katherine L Zavodni; Enrikas Vainorius; Jennifer F Kherani; Pascal J Goldschmidt-Clermont; Eric D Peterson
Journal:  Am Heart J       Date:  2008-12-09       Impact factor: 4.749

7.  Aging and endothelial progenitor cell telomere length in healthy men.

Authors:  Erich J Kushner; Gary P Van Guilder; Owen J Maceneaney; Jennifer N Cech; Brian L Stauffer; Christopher A DeSouza
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

8.  Prehypertension and endothelial progenitor cell function.

Authors:  O J MacEneaney; C A DeSouza; B R Weil; E J Kushner; G P Van Guilder; M L Mestek; J J Greiner; B L Stauffer
Journal:  J Hum Hypertens       Date:  2010-03-25       Impact factor: 3.012

9.  Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk.

Authors:  Lawrence F Bielak; Richard B Horenstein; Kathleen A Ryan; Patrick F Sheedy; John A Rumberger; Keith Tanner; Wendy Post; Braxton D Mitchell; Alan R Shuldiner; Patricia A Peyser
Journal:  Clin Med Cardiol       Date:  2009-05-27

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.